Steris Stock Near Record Highs: Safe Haven Play or Priced for Perfection?

Steris plc (STE) has significantly outperformed the S&P 500, driven by stable hospital demand and essential infection-prevention solutions. While the stock offers defensive qualities and predictable growth, its current premium valuation poses a key risk to future returns. Investors should weigh its stability and consistent performance against its elevated price, considering it more as a steady compounder for portfolio anchoring than a high-growth opportunity.